Welcome to our dedicated page for Ontrak news (Ticker: OTRK), a resource for investors and traders seeking the latest updates and insights on Ontrak stock.
Ontrak, Inc. (OTRK), also referred to as Ontrak Health, has generated a stream of news centered on its role as a value-based, AI-powered behavioral healthcare company and, later, on significant financing and corporate developments. Company press releases describe how Ontrak uses a proprietary Advanced Engagement System, AI, and predictive analytics to identify and engage vulnerable members of the behavioral health population, including individuals with anxiety, depression, substance use disorder, and chronic disease. News items frequently discuss its WholeHealth+, Engage, and Quality solutions, which are aimed at improving clinical outcomes and reducing total cost of care for health plans and other payors.
Visitors to the OTRK news page can review announcements about partnerships with health plans and health systems, such as agreements with Sentara Health Plans and Intermountain Health, as well as Medicaid provider designations obtained through an affiliated practice association in two states. These stories outline how Ontrak’s programs are deployed across Medicare Advantage, Medicaid, Commercial, and Marketplace populations, and how the company positions itself as a technology-enabled behavioral health partner.
The news flow also includes financial results releases, highlighting revenue trends, operating losses, and non-GAAP metrics, along with details of public offerings, financing commitments from Acuitas Capital LLC, and amendments to the company’s Keep Well Agreement. Later disclosures and filings referenced in press releases and SEC documents describe challenges such as customer concentration, the loss of a major prospect, and the company’s efforts to secure additional capital.
For investors and researchers, the OTRK news page provides a chronological view of how Ontrak presented its mission, solutions, customer relationships, and financial condition over time. It also offers context for key turning points, including the board’s decision to cease operations and subsequent Nasdaq delisting actions documented in SEC filings. Reviewing this news archive alongside regulatory filings can help users understand both the company’s behavioral health strategy and the risks that emerged in its business model.
Ontrak, Inc. (NASDAQ: OTRK) has signed an amendment with Optima Health to enhance its Wholehealth+ care program targeting high-acuity, cost-prohibitive members in their commercial line. This agreement leverages Ontrak’s AI-enabled Advanced Engagement System for real-time feedback and improved health outcomes. Expected to launch in January 2023, the amendment could boost Ontrak's outreach by 10-15%. Both organizations emphasize member health improvements as central to the partnership.
Ontrak, Inc. (NASDAQ: OTRK) announced the publication of its Treatment Effect Study in the American Journal of Managed Care. The study reports a significant $485 PMPM savings over 24 months, mainly from a 66% reduction in inpatient visits among 900 members enrolled in the Ontrak WholeHealth+ program. Key findings include sustained savings, increased office visits, and a push toward integrating behavioral health interventions in the healthcare system to support value-based care. These results validate Ontrak's approach to improving healthcare outcomes.
On December 6, 2022, Ontrak, Inc. (OTRK, OTRKP) received a notice from Nasdaq indicating non-compliance with the minimum bid price requirement, having traded below $1.00 for 30 consecutive business days. The company has a 180-day grace period until June 5, 2023, to restore compliance by achieving a minimum closing bid price of $1.00 for at least 10 consecutive days. There is no immediate impact on the stock's listing, but the company is exploring options to regain compliance, with no assurance of success.
Ontrak, Inc. (NASDAQ: OTRK) reported Q3 2022 revenue of $2.8 million, an 85% decline compared to the previous year. The company experienced a net loss of $(12.8) million, or $(0.62) per share. To enhance its financial position, Ontrak fully repaid a $7.5 million loan and secured $3.3 million in a direct share offering. The company confirmed its 2022 revenue outlook of $14 to $16 million and noted progress in its sales pipeline, aiming for growth in 2023. Adjusted EBITDA was $(7.7) million, up from $(1.7) million in Q3 2021.
Ontrak, Inc. (NASDAQ: OTRK) will report its third-quarter 2022 financial results on November 9, 2022, after market close. A conference call will be held at 1:30 p.m. PT / 4:30 p.m. ET. Investors can access the call via registration or through a live audio webcast. Ontrak leverages AI and telehealth to support behavioral health, emphasizing personalized care for vulnerable populations dealing with anxiety, depression, and substance use disorders.
Ontrak, Inc. (NASDAQ: OTRK) announced the appointment of James Messina as a non-Executive Director to its board. With extensive experience in healthcare, Messina previously served as Executive VP and COO for Premera Blue Cross and held leadership roles at CIGNA and UnitedHealth Group. His expertise is expected to enhance Ontrak’s mission of improving behavioral health services. Terren Peizer, CEO, expressed enthusiasm for Messina's contributions, emphasizing the importance of tailored support for individuals with behavioral health needs.
Ontrak, Inc. (NASDAQ: OTRK) has announced its participation in the Inaugural Gilmartin Group Emerging Growth Company Showcase, set for August 31, 2022, at 1:00 p.m. ET. The virtual event will feature a presentation by company management. Interested parties can access the live webcast here, and an archived version will be available on the company’s website, highlighting Ontrak's mission to improve healthcare for vulnerable populations using AI and telehealth solutions.
Ontrak, Inc. (NASDAQ: OTRK) reported Q2 2022 revenue of $3.9 million, an 85% decrease from the previous year, with a net loss of $15.1 million ($0.83 per share).
To manage its finances, the company fully repaid a $19.2 million loan, with a $5 million draw from its Keep Well Agreement.
Ontrak raised $3.5 million via a registered direct offering and partnered with Eleos for AI integration, reflecting progress in their sales pipeline with 19 health plan prospects.
The company forecasts 2022 revenue between $14 million and $16 million.
Ontrak, Inc. (NASDAQ: OTRK) has completed a registered direct offering, raising approximately $4.0 million by selling shares at $0.80 each, adhering to Nasdaq's at-the-market rules. Roth Capital Partners acted as the placement agent. The funds will be utilized for working capital and to reduce outstanding debt. This transaction followed a previously filed shelf registration statement with the SEC. The offering aims to strengthen Ontrak's financial position and support its mission in healthcare.
Ontrak, Inc. (NASDAQ: OTRK) announced a securities purchase agreement for a registered direct offering of its common stock at $0.80 per share, raising approximately $4.0 million before fees. The offering, expected to close by August 4, 2022, aims to fund working capital and reduce debt. Roth Capital Partners serves as the exclusive placement agent. The shares are being offered under a previously filed shelf registration statement with the SEC.